求文献两篇

w2503

$ ?/ ]2 a; F+ ~" z
% Z4 ~! a9 }, R9 z7 X. o
1. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials
, |4 n1 R) S+ ^/ Q# Ghttp://www.ncbi.nlm.nih.gov/pubmed/3305708' t& p# _/ P4 ?& q( O, F

* W3 F* D0 x: @6 rhttp://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T2Y-4WDXS7B-M&_user=2352871&_coverDate=08%2F24%2F1987&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_searchStrId=1702764138&_rerunOrigin=google&_acct=C000057039&_version=1&_urlVersion=0&_userid=2352871&md5=78ea2446e8395b3e814a09d447cf465a&searchtype=a
7 @2 ]$ g  {( a; D* Y2 t
" S# ]0 O* t5 M, L
6 Q, r6 ]% z" Q% P! w2. T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes
: M- f9 k, H4 d6 F) T- O2 Shttp://www.ncbi.nlm.nih.gov/pubmed/110692224 V( i9 w; S5 g8 x3 A+ U8 [" z1 S4 f

0 T# p( h1 ]! k' C谢谢

w2503

请大家帮帮忙，谢谢

xyklmu

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials- o5 h, L# v  S) T3 h8 E& L
/ l+ e7 d; o2 L# F5 x

; H- k, _! L9 k: v# O+ ^- w6 p0 z
3 T3 x  Q$ i2 K$ y6 m/ w8 ^

' Y! K% L1 U! j* ?/ z

xyklmu

T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes  ' _* h1 V' @! _4 N. B
  O1 h  V* O1 l( m, |
4 D4 c8 Q4 O$ L$ I8 V" k7 E* P4 m0 v
& p3 Y) B1 [! x0 N3 O; w$ |7 p

( k' M" F1 E5 S& s4 ^& g" a' [( k. B( _7 O! ]/ b  ]8 g3 ]! N, o; d

2 J9 ?& h* d% v6 |/ i9 M+ |

w2503

回复 xyklmu 的帖子" _/ h' B" o# w( @2 q- c# f/ j/ Q4 h

  L' c) f" T8 E) e. n% {& @非常非常感谢